115 related articles for article (PubMed ID: 3914253)
1. Enhancement by cyclophosphamide of experimental pulmonary metastases formation of Lewis lung carcinoma. II. Reduction of the cyclophosphamide effect by repopulation with cells from lymphoid organs.
Strzadała L; Rak J; Kuśnierczyk H
Arch Immunol Ther Exp (Warsz); 1985; 33(6):831-6. PubMed ID: 3914253
[TBL] [Abstract][Full Text] [Related]
2. Enhancement by cyclophosphamide of experimental pulmonary metastases formation of Lewis lung carcinoma. I. Dose-dependence and kinetics of cyclophosphamide effect.
Strzadała L; Rak J; Kuśnierczyk H
Arch Immunol Ther Exp (Warsz); 1985; 33(6):825-9. PubMed ID: 3833119
[TBL] [Abstract][Full Text] [Related]
3. The influence of cyclophosphamide on antibody formation in the mouse.
Willers JM; Sluis E
Ann Immunol (Paris); 1975 Apr; 126(3):267-79. PubMed ID: 1101799
[TBL] [Abstract][Full Text] [Related]
4. Potentiation of cyclophosphamide-induced enhancement of experimental metastasis by splenectomy.
Strzadała L; Rak J; Zioło E; Kuśnierczyk H; Radzikowski C
Arch Immunol Ther Exp (Warsz); 1989; 37(3-4):399-403. PubMed ID: 2639636
[TBL] [Abstract][Full Text] [Related]
5. Antitumour and antimetastatic effect of genistein alone or combined with cyclophosphamide in mice transplanted with various tumours depends on the route of tumour transplantation.
Wietrzyk J; Opolski A; Madej J; Radzikowski C
In Vivo; 2000; 14(2):357-62. PubMed ID: 10836210
[TBL] [Abstract][Full Text] [Related]
6. Indirect effect of cyclophosphamide on the lung tumor colony formation and on the conditioned media activity.
Janik P; Szaniawska B
Neoplasma; 1984; 31(1):37-42. PubMed ID: 6700793
[TBL] [Abstract][Full Text] [Related]
7. Increased metastatic capacity of Lewis lung tumor cells by in vivo selection procedure.
Pál K; Kopper L; Lapis K
Invasion Metastasis; 1983; 3(3):174-82. PubMed ID: 6677625
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of the distribution of thymus and marrow cells in the peripheral lymphoid organs of the mouse: ecotaxis.
de Sousa M
Clin Exp Immunol; 1971 Sep; 9(3):371-80. PubMed ID: 5571056
[TBL] [Abstract][Full Text] [Related]
9. The antitumor effect of postoperative treatment with genistein alone or combined with cyclophosphamide in mice bearing transplantable tumors.
Wietrzyk J; Opolski A; Madej J; Radzikowski C
Acta Pol Pharm; 2000 Nov; 57 Suppl():5-8. PubMed ID: 11293263
[TBL] [Abstract][Full Text] [Related]
10. Frequencies of background cytoplasmic Ig-containing cells in various lymphoid organs of athymic and euthymic mice as a function of age and immune status.
Van Oudenaren A; Haaijman JJ; Benner R
Immunology; 1984 Apr; 51(4):735-42. PubMed ID: 6231241
[TBL] [Abstract][Full Text] [Related]
11. Selectivity of the antimetastatic and cytotoxic effects of 1-p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt (+/-)-1,2-di(3,5-dioxopiperazin-1-yl)propane, and cyclophosphamide in mice bearing Lewis lung carcinoma.
Giraldi T; Sava G; Cuman R; Nisi C; Lassiani L
Cancer Res; 1981 Jun; 41(6):2524-8. PubMed ID: 7237446
[TBL] [Abstract][Full Text] [Related]
12. [Restoration of immunologic reactivity to tolerant or cyclophosphamide treated mice by administration of syngenous thymus cells].
Pevnitskiĭ LA
Biull Eksp Biol Med; 1973 Apr; 75(4):62-6. PubMed ID: 4614873
[No Abstract] [Full Text] [Related]
13. Graft versus leukemia for "cell cure" of long-passage AKR leukemia after chemoradiotherapy.
Saltzstein EC; Glasspiegel JS; Rimm AA; Giller RH; Bortin MM
Cancer Res; 1972 Aug; 32(8):1658-62. PubMed ID: 4402951
[No Abstract] [Full Text] [Related]
14. Toxicology and carcinogenesis studies of indium phosphide (CAS No. 22398-90-7) in F344/N rats and B6C3F1 mice (inhalation studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2001 Jul; (499):7-340. PubMed ID: 12087422
[TBL] [Abstract][Full Text] [Related]
15. Leech salivary gland extract from Haementeria officinalis, a potent inhibitor of cyclophosphamide- and radiation-induced artificial metastasis enhancement.
Gasic GJ; Iwakawa A; Gasic TB; Viner ED; Milas L
Cancer Res; 1984 Dec; 44(12 Pt 1):5670-6. PubMed ID: 6498828
[TBL] [Abstract][Full Text] [Related]
16. Effect of cyclophosphamide-induced elimination of lymphocytes from the spleen and lymph node on immune response in mice.
Konys J; Mackiewicz U; Drygas J
Arch Immunol Ther Exp (Warsz); 1981; 29(6):783-8. PubMed ID: 7349098
[TBL] [Abstract][Full Text] [Related]
17. Influence of IL-10 on murine CFU-pre-B formation.
Fine JS; Macosko HD; Grace MJ; Narula SK
Exp Hematol; 1994 Nov; 22(12):1188-96. PubMed ID: 7925782
[TBL] [Abstract][Full Text] [Related]
18. Lewis lung carcinoma in mice as an experimental therapy model. II. The effect of BCNU, cyclophosphamide and/or surgery treatment on early and advanced tumor in mice.
Budzyński W
Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):373-7. PubMed ID: 7184488
[TBL] [Abstract][Full Text] [Related]
19. LL2 cell line derived from transplantable murine Lewis lung carcinoma--maintenance in vitro and growth characteristics.
Duś D; Budzyński W; Radzikowski C
Arch Immunol Ther Exp (Warsz); 1985; 33(6):817-23. PubMed ID: 3833118
[TBL] [Abstract][Full Text] [Related]
20. Weakening of genetic resistance. II. The effect of injection of the macrophage toxic agents silica and carragheenan and the cytostatic drugs cyclophosphamide, busulphan and vinblastin.
Buurman WA; van Bruggen I
Exp Hematol; 1976 Nov; 4(6):382-92. PubMed ID: 186293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
